Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center

Abstract Acute lymphoid leukemia is a childhood cancer that in high-income countries has event-free survival rates of 80% and global survival rates of 90%. In Brazil these rates are under 70%. This difference may be due to the implementation of supportive care, including the assessment of asparagina...

Full description

Bibliographic Details
Main Authors: Daiane Keller Cecconello, Ciliana Rechenmacher, Isabel Werlang, Priscila Pini Zenatti, Jose Andres Yunes, Ana Paula Alegretti, Claudia Lanvers-Kaminsky, Liane Esteves Daudt, Mariana Bohns Michalowski
Format: Article
Language:English
Published: Nature Portfolio 2020-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-78549-y
_version_ 1818752470298394624
author Daiane Keller Cecconello
Ciliana Rechenmacher
Isabel Werlang
Priscila Pini Zenatti
Jose Andres Yunes
Ana Paula Alegretti
Claudia Lanvers-Kaminsky
Liane Esteves Daudt
Mariana Bohns Michalowski
author_facet Daiane Keller Cecconello
Ciliana Rechenmacher
Isabel Werlang
Priscila Pini Zenatti
Jose Andres Yunes
Ana Paula Alegretti
Claudia Lanvers-Kaminsky
Liane Esteves Daudt
Mariana Bohns Michalowski
author_sort Daiane Keller Cecconello
collection DOAJ
description Abstract Acute lymphoid leukemia is a childhood cancer that in high-income countries has event-free survival rates of 80% and global survival rates of 90%. In Brazil these rates are under 70%. This difference may be due to the implementation of supportive care, including the assessment of asparaginase (ASNase) activity. ASNase may cause hypersensitivity reactions and silent drug inactivation. For this reason, ASNase activity monitoring is an essential tool to ensure an effective treatment. Our aim was to implement an ASNase activity measurement technique at a hospital setting. samples from children who were given Escherichia coli-derived ASNase were collected. The results of the analyses conducted in our laboratory Hospital de Clínicas de Porto Alegre were compared to those of two institutions: Centro Infantil Boldrini and University of Munster. 262 samples were assessed. The results of the first analyses were compared with those obtained at Centro Infantil Boldrini and showed an ICC of 0.954. Thirty samples were sent to the University of Munster and presented an ICC was 0.960. Our results, when compared to those of national and international centers, showed an excellent agreement. The study was able to implement an ASNase activity test to monitor the treatment.
first_indexed 2024-12-18T04:51:58Z
format Article
id doaj.art-3f0393b11e36490cb2ac7fd60d863415
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-18T04:51:58Z
publishDate 2020-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-3f0393b11e36490cb2ac7fd60d8634152022-12-21T21:20:23ZengNature PortfolioScientific Reports2045-23222020-12-011011610.1038/s41598-020-78549-yImplementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian CenterDaiane Keller Cecconello0Ciliana Rechenmacher1Isabel Werlang2Priscila Pini Zenatti3Jose Andres Yunes4Ana Paula Alegretti5Claudia Lanvers-Kaminsky6Liane Esteves Daudt7Mariana Bohns Michalowski8Graduate Program in Child and Adolescent Health, Universidade Federal do Rio Grande do SulGraduate Program in Child and Adolescent Health, Universidade Federal do Rio Grande do SulTranslational Pediatrics Laboratory, Experimental Research Center, Hospital de Clínicas de Porto AlegreCentro Infantil BoldriniCentro Infantil BoldriniHospital de Clínicas de Porto AlegreUniversity Children’s Hospital of MünsterGraduate Program in Child and Adolescent Health, Universidade Federal do Rio Grande do SulGraduate Program in Child and Adolescent Health, Universidade Federal do Rio Grande do SulAbstract Acute lymphoid leukemia is a childhood cancer that in high-income countries has event-free survival rates of 80% and global survival rates of 90%. In Brazil these rates are under 70%. This difference may be due to the implementation of supportive care, including the assessment of asparaginase (ASNase) activity. ASNase may cause hypersensitivity reactions and silent drug inactivation. For this reason, ASNase activity monitoring is an essential tool to ensure an effective treatment. Our aim was to implement an ASNase activity measurement technique at a hospital setting. samples from children who were given Escherichia coli-derived ASNase were collected. The results of the analyses conducted in our laboratory Hospital de Clínicas de Porto Alegre were compared to those of two institutions: Centro Infantil Boldrini and University of Munster. 262 samples were assessed. The results of the first analyses were compared with those obtained at Centro Infantil Boldrini and showed an ICC of 0.954. Thirty samples were sent to the University of Munster and presented an ICC was 0.960. Our results, when compared to those of national and international centers, showed an excellent agreement. The study was able to implement an ASNase activity test to monitor the treatment.https://doi.org/10.1038/s41598-020-78549-y
spellingShingle Daiane Keller Cecconello
Ciliana Rechenmacher
Isabel Werlang
Priscila Pini Zenatti
Jose Andres Yunes
Ana Paula Alegretti
Claudia Lanvers-Kaminsky
Liane Esteves Daudt
Mariana Bohns Michalowski
Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center
Scientific Reports
title Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center
title_full Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center
title_fullStr Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center
title_full_unstemmed Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center
title_short Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center
title_sort implementation of the asparaginase activity assessment technique for clinical use experience of a brazilian center
url https://doi.org/10.1038/s41598-020-78549-y
work_keys_str_mv AT daianekellercecconello implementationoftheasparaginaseactivityassessmenttechniqueforclinicaluseexperienceofabraziliancenter
AT cilianarechenmacher implementationoftheasparaginaseactivityassessmenttechniqueforclinicaluseexperienceofabraziliancenter
AT isabelwerlang implementationoftheasparaginaseactivityassessmenttechniqueforclinicaluseexperienceofabraziliancenter
AT priscilapinizenatti implementationoftheasparaginaseactivityassessmenttechniqueforclinicaluseexperienceofabraziliancenter
AT joseandresyunes implementationoftheasparaginaseactivityassessmenttechniqueforclinicaluseexperienceofabraziliancenter
AT anapaulaalegretti implementationoftheasparaginaseactivityassessmenttechniqueforclinicaluseexperienceofabraziliancenter
AT claudialanverskaminsky implementationoftheasparaginaseactivityassessmenttechniqueforclinicaluseexperienceofabraziliancenter
AT lianeestevesdaudt implementationoftheasparaginaseactivityassessmenttechniqueforclinicaluseexperienceofabraziliancenter
AT marianabohnsmichalowski implementationoftheasparaginaseactivityassessmenttechniqueforclinicaluseexperienceofabraziliancenter